1. Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors

   • G. J. Peters
   • P. Noordhuis
   • C. J. Van Groeningen

   Original Article 09 May 2003 Pages: 1 - 12

   

2. Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial

   • Joseph T. Santoso
   • Joseph A. Lucci III
   • Edward V. Hannigan

   Original Article 29 April 2003 Pages: 13 - 18

   

3. Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial

   • Seiji Niho
   • Kaoru Kubota
   • Yutaka Nishiwaki

   Original Article 24 April 2003 Pages: 19 - 24

   

4. Pharmacokinetics and tissue distribution of cryptophycin 52 (C-52) epoxide and cryptophycin 55 (C-55) chlorohydrin in mice with subcutaneous tumors

   • Ramesh R. Boinpally
   • Lisa Polin
   • Ralph E. Parchment

   Original Article 09 May 2003 Pages: 25 - 33

   

5. A population model of epirubicin pharmacokinetics and application to dosage guidelines

   • Lorraine D. Ralph
   • Alison H. Thomson
   • Chris Twelves

   Original Article 23 May 2003 Pages: 34 - 40

   

6. Combined effects of temozolomide and the ribonucleotide reductase inhibitors didox and trimidox in malignant brain tumor cells

   • M. Figul
   • A. Söling
   • N. G. Rainov

   Original Article 11 April 2003 Pages: 41 - 46

   

7. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3

   • Xiao-Mei Hu
   • Toshihiko Hirano
   • Kitaro Oka

   Original Article 16 May 2003 Pages: 47 - 58

   

8. An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasis

   • Devendra S. Dandekar
   • Vinata B. Lokeshwar
   • Balakrishna L. Lokeshwar

   Original Article 07 May 2003 Pages: 59 - 66

   

9. Phase I and pharmacokinetic study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer

   • M. Ichiki
   • R. Gohara
   • H. Aizawa

   Original Article 13 May 2003 Pages: 67 - 72

   

10. Phase I/II study of escalating doses of nedaplatin in combination with irinotecan for advanced non-small-cell lung cancer

    • Fumihiro Oshita
    • Kouzo Yamada
    • Haruhiro Saito

    Original Article 16 May 2003 Pages: 73 - 78

11. Pharmacokinetic and pharmacodynamic effects of oral eniluracil, fluorouracil and leucovorin given on a weekly schedule

    • Xiao-Du Guo
    • Nancy Harold
    • Jean L. Grem

    Original Article 18 April 2003 Pages: 79 - 85

    

12. Clinical effects of combination therapy with mitoxantrone, vincristine, and prednisolone in breast cancer

    • Kenji Katsumata
    • Hidenori Tomioka
    • Yasuhisa Koyanagi

    Short Communication 23 May 2003 Pages: 86 - 88